• Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Buy Rating from Needham & Company LLC

    Source: Buzz FX / 28 Feb 2025 07:51:14   America/Chicago


    Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Buy Rating from Needham & Company LLC Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Rhythm Pharmaceuticals ( NASDAQ:RYTM - Get Free Report ) 's stock had its "buy" rating
    Read more...
Share on,